Lantern Pharma Inc.
LTRN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $34 | $38 | $34 |
| - Cash | $8 | $6 | $6 | $8 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | $28 | $32 | $27 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | $0 | $0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$4 | -$5 | -$5 | -$6 |
| % Margin | – | – | – | – |
| Net Income | -$4 | -$4 | -$5 | -$6 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.39 | -0.4 | -0.42 | -0.54 |
| % Growth | 2.5% | 4.8% | 22.2% | – |
| Operating Cash Flow | -$5 | -$4 | -$4 | -$4 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$5 | -$4 | -$4 | -$4 |